Age-related changes in rat myocardium involve altered capacities of glycosaminoglycans to potentiate growth factor functions and heparan sulfate-altered sulfation

Journal of Biological Chemistry

Volumn 287, Issue 14, 2012, Pages 11363-11373

  Huynh, Minh Bao ^a   Morin, Christophe ^a   Carpentier, Gilles ^a   Garcia Filipe, Stephanie ^a   Talhas Perret, Sofia ^a   Barbier Chassefière, Véronique ^a   Van Kuppevelt, Toin H ^b   Martelly, Isabelle ^a   Albanese, Patricia ^a   Papy Garcia, Dulce ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGE-RELATED CHANGES; AGING PROCESS; CARDIAC TISSUES; CELL BEHAVIORS; CULTURED CELL; ESSENTIAL COMPONENT; EXTRACELLULAR MATRICES; GLYCOSAMINOGLYCANS; GROWTH FACTOR; HEPARAN; HEPARAN SULFATES; HEPARIN BINDING; LEFT VENTRICLES; MITOGENIC; NATURAL ENVIRONMENTS; PATHOLOGICAL PROCESS; TISSUE HOMEOSTASIS;

CELL PROLIFERATION; PHYSIOLOGY; POLYSACCHARIDES; TISSUE;

PEPTIDES;

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; VASCULOTROPIN 165;

AGED; AGING; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE ANALYSIS; CARDIAC TISSUE INTEGRITY; CELL CULTURE; CELL HOMING; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART DISEASE; HEART LEFT VENTRICLE; HEART MUSCLE; HOMEOSTASIS; HUMAN; HUMAN CELL; MALE; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; RAT; SULFATION; TISSUE REPAIR; TISSUE STRUCTURE;

AGING; ANIMALS; DISACCHARIDES; FIBROBLAST GROWTH FACTOR 2; GLYCOSAMINOGLYCANS; HEART VENTRICLES; HEPARITIN SULFATE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MYOCARDIUM; RATS; RATS, WISTAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

RATTUS;

EID: 84859489134     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.335901     Document Type: Article

References (40)

1. Marastoni, S., Ligresti, G., Lorenzon, E., Colombatti, A., and Mongiat, M. (2008) Extracellular matrix: a matter of life and death. Connect. Tissue Res. 49, 203-206
2. Najafi, F., Jamrozik, K., and Dobson, A. J. (2009) Understanding the "epidemic of heart failure": a systematic review of trends in determinants of heart failure. Eur. J. Heart Fail. 11, 472-479
3. Yung, S., and Chan, T. M. (2007) Glycosaminoglycans and proteoglycans: overlooked entities? Perit. Dial. Int. 27, S104-109 (Pubitemid 350047685)
4. Ori, A., Wilkinson, M. C., and Fernig, D. G. (2008) The heparanome and regulation of cell function: structures, functions and challenges. Front. Biosci. 13, 4309-4338 (Pubitemid 351599686)
5. Sasisekharan, R., and Venkataraman, G. (2000) Heparin and heparan sulfate: biosynthesis, structure and function. Curr. Opin. Chem. Biol. 4, 626-631
6. Zakrzewska, M., Marcinkowska, E., and Wiedlocha, A. (2008) FGF-1: from biology through engineering to potential medical applications. Crit. Rev. Clin. Lab. Sci. 45, 91-135 (Pubitemid 351299654)
7. Beenken, A., and Mohammadi, M. (2009) The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235-253
8. Kardami, E., Detillieux, K., Ma, X., Jiang, Z., Santiago, J. J., Jimenez, S. K., and Cattini, P. A. (2007) Fibroblast growth factor-2 and cardioprotection. Heart Fail. Rev. 12, 267-277 (Pubitemid 350176700)
9. Gaffney, M. M., Hynes, S. O., Barry, F., and O'Brien, T. (2007) Cardiovascular gene therapy: current status and therapeutic potential. Br. J. Pharmacol. 152, 175-188 (Pubitemid 47517600)
10. Lavu, M., Gundewar, S., and Lefer, D. J. (2011) Gene therapy for ischemic heart disease. J. Mol. Cell Cardiol. 50, 742-750
11. Prokopi, M., and Mayr, M. (2011) The article is Proteomics: a reality-check for putative stem cells. Circ. Res. 108, 499-511
12. Barbosa, I., Garcia, S., Barbier-Chassefière, V., Caruelle, J. P., Martelly, I., and Papy-García, D. (2003) Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies. Glycobiology 13, 647-653 (Pubitemid 37220443)
13. Najjam, S., Gibbs, R. V., Gordon, M. Y., and Rider, C. C. (1997) The binding of interleukin 2 to heparin revealed by a novel ELISA method. Biochem. Soc. Trans. 25, 3S (Pubitemid 27092608)
14. Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E., and Leder, P. (1992) Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol. 12, 240-247
15. Rouet, V., Hamma-Kourbali, Y., Petit, E., Panagopoulou, P., Katsoris, P., Barritault, D., Caruelle, J. P., and Courty, J. (2005) A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis. J. Biol. Chem. 280, 32792-32800 (Pubitemid 41368326)
16. Gillies, R. J., Didier, N., and Denton, M. (1986) Determination of cell number in monolayer cultures. Anal. Biochem. 159, 109-113 (Pubitemid 17228232)
17. Blondet, B., Carpentier, G., Lafdil, F., and Courty, J. (2005) Pleiotrophin cellular localization in nerve regeneration after peripheral nerve injury. J. Histochem. Cytochem. 53, 971-977 (Pubitemid 41045420)
18. Blondet, B., Carpentier, G., Ferry, A., and Courty, J. (2006) Exogenous pleiotrophin applied to lesioned nerve impairs muscle reinnervation. Neurochem. Res. 31, 907-913 (Pubitemid 44134244)
19. Toyoda, H., Yamamoto, H., Ogino, N., Toida, T., and Imanari, T. (1999) Rapid and sensitive analysis of disaccharides composition in heparin and heparan sulfate by reverse phase ion pair chromatography on a 2 mm porous silica gel column. J. Chromatog. A 830, 197-201 (Pubitemid 29034693)
20. Kurup, S., Wijnhoven, T. J., Jenniskens, G. J., Kimata, K., Habuchi, H., Li J. P., Lindahl, U., van Kuppevelt, T. H., and Spillmann, D. (2007) Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4. J. Biol. Chem. 282, 21032-21042 (Pubitemid 47099935)
21. Wijnhoven, T. J., van de Westerlo, E. M., Smits, N. C., Lensen, J. F., Rops, A. L., van der Vlag, J., Berden, J. H., van den Heuvel, L. P., and van Kuppevelt, T. H. (2008) Characterization of anticoagulant heparinoids by immunoprofiling. Glycoconj. J. 25, 177-185 (Pubitemid 351238194)
22. Smits, N. C., Kurup, S., Rops, A. L., ten Dam, G. B., Massuger, L. F., Hafmans, T., Turnbull, J. E., Spillmann, D., Li J. P., Kennel, S. J., Wall, J. S., Shworak, N. W., Dekhuijzen, P. N., van der Vlag, J., and van Kuppevelt, T. H. (2010) The heparan sulfate motif (GlcNS6S-IdoA2S)3, common in heparin, has a strict topography and is involved in cell behavior and disease. J. Biol. Chem. 285, 41143-41151
23. Lensen, J. F., Rops, A. L., Wijnhoven, T. J., Hafmans, T., Feitz, W. F., Oosterwijk, E., Banas, B., Bindels, R. J., van den Heuvel, L. P., van der Vlag, J., Berden, J. H., and van Kuppevelt, T. H. (2005) Localization and functional characterization of glycosaminoglycan domains in the normal human kidney as revealed by phage display-derived single chain antibodies. J. Am. Soc. Nephrol. 16, 1279-1288 (Pubitemid 41716512)
24. Wijnhoven, T. J., Lensen, J. F., Rops, A. L., van der Vlag, J., Kolset, S. O., Bangstad, H. J., Pfeffer, P., van den Hoven, M. J., Berden, J. H., van den Heuvel, L. P., and van Kuppevelt, T. H. (2006) Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics. Am. J. Kidney Dis. 48, 250-261 (Pubitemid 44069615)
25. Smits, N. C., Robbesom, A. A., Versteeg, E. M., van de Westerlo, E. M., Dekhuijzen, P. N., and van Kuppevelt, T. H. (2004) Heterogeneity of heparan sulfates in human lung. Am. J. Respir. Cell Mol. Biol. 30, 166-173 (Pubitemid 38147201)
26. Ten Dam, G. B., Kurup, S., van de Westerlo, E. M., Versteeg, E. M., Lindahl, U., Spillmann, D., and van Kuppevelt, T. H. (2006) 3-O-Sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J. Biol. Chem. 281, 4654-4662 (Pubitemid 43847724)
27. Lensen, J. F., Wijnhoven, T. J., Kuik, L. H., Versteeg, E. M., Hafmans, T., Rops, A. L., Pavao, M. S., van der Vlag, J., van den Heuvel, L. P., Berden, J. H., and van Kuppevelt, T. H. (2006) Selection and characterization of a unique phage display-derived antibody against dermatan sulfate. Matrix Biol. 25, 457-461 (Pubitemid 44515191)
28. Smetsers, T. F., van de Westerlo, E. M., ten Dam G. B., Overes, I. M., Schalkwijk, J., van Muijen G. N., and van Kuppevelt, T. H. (2004) Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J. Invest. Dermatol. 122, 707-716 (Pubitemid 38471340)
29. Ten Dam, G. B., Yamada, S., Kobayashi, F., Purushothaman, A., van de Westerlo, E. M., Bulten, J., Malmström, A., Sugahara, K., Massuger, L. F., and van Kuppevelt, T. H. (2009) Dermatan sulfate domains defined by the novel antibody GD3A12, in normal tissues and ovarian adenocarcinomas. Histochem. Cell Biol. 132, 117-127
30. Purushothaman, A., Fukuda, J., Mizumoto, S., ten Dam, G. B., van Kuppevelt, T. H., Kitagawa, H., Mikami, T., and Sugahara, K. (2007) Functions of chondroitin sulfate/dermatan sulfate chains in brain development: critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7. J. Biol. Chem. 282, 19442-19452 (Pubitemid 47100083)
31. Deschamps, A. M., and Spinale, F. G. (2005) Matrix modulation and heart failure: new concepts question old beliefs. Curr. Opin. Cardiol. 20, 211-216 (Pubitemid 40704878)
32. Narita, K., Staub, J., Chien, J., Meyer, K., Bauer, M., Friedl, A., Ramakrishnan, S., and Shridhar, V. (2006) HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res. 66, 6025-6032
33. Frese, M. A., Milz, F., Dick, M., Lamanna, W. C., and Dierks, T. (2009) Characterization of the human sulfatase Sulf1 and its high affinity heparin/heparan sulfate interaction domain. J. Biol. Chem. 284, 28033-28044
34. Stringer, S. E. (2006) The role of heparan sulphate proteoglycans in angiogenesis. Biochem. Soc. Trans. 34, 451-453
35. Zhang, X., Ibrahimi, O. A., Olsen, S. K., Umemori, H., Mohammadi, M., and Ornitz, D. M. (2006) Receptor specificity of the fibroblast growth factor family: the complete mammalian FGF family. J. Biol. Chem. 281, 15694-15700 (Pubitemid 43848456)
36. Ashikari-Hada, S., Habuchi, H., Sugaya, N., Kobayashi, T., and Kimata, K. (2009) Specific inhibition of FGF-2 signaling with 2-O-sulfated octasaccharides of heparan sulfate. Glycobiology 19, 644-654
37. Chu, C. L., Goerges, A. L., and Nugent, M. A. (2005) Identification of common and specific growth factor binding sites in heparan sulfate proteoglycans. Biochemistry 44, 12203-12213 (Pubitemid 41285719)
38. Naiki, H., and Nagai, Y. (2009) Molecular pathogenesis of protein misfolding diseases: pathological molecular environments versus quality control systems against misfolded proteins. J. Biochem. 146, 751-756
39. Wang, X., Su, H., and Ranek, M. J. (2008) Protein quality control and degradation in cardiomyocytes. J. Mol. Cell. Cardiol. 45, 11-27
40. Wang, X., and Robbins, J. (2006) Heart failure and protein quality control. Circ. Res. 99, 1315-1328 (Pubitemid 44949667)